The estimated Net Worth of Thomas Wegman is at least $105 Million dollars as of 16 August 2018. Thomas Wegman owns over 23,592 units of Biospecifics Technologies stock worth over $83,879,785 and over the last 15 years Thomas sold BSTC stock worth over $21,046,415.
Sign up
Thomas Wegman BSTC stock SEC Form 4 insiders trading
Thomas has made over 26 trades of the Biospecifics Technologies stock since 2009, according to the Form 4 filled with the SEC. Most recently Thomas sold 23,592 units of BSTC stock worth $1,210,270 on 16 August 2018.
The largest trade Thomas's ever made was selling 150,000 units of Biospecifics Technologies stock on 13 September 2010 worth over $3,525,000. On average, Thomas trades about 35,344 units every 112 days since 2009. As of 16 August 2018 Thomas still owns at least 947,473 units of Biospecifics Technologies stock.
You can see the complete history of Thomas Wegman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Thomas Wegman's mailing address?
Thomas's mailing address filed with the SEC is 1764 BRIAR PLACE, , MERRICK, NY, 11566.
Insiders trading at Biospecifics Technologies
Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo, and Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.
What does Biospecifics Technologies's logo look like?
Complete history of Thomas Wegman stock trades at Biospecifics Technologies
Biospecifics Technologies executives and stock owners
Biospecifics Technologies executives and other stock owners filed with the SEC include:
-
Jennifer Chao,
Independent Chairman of the Board -
Michael Schamroth,
Independent Director -
Paul Gitman,
Independent Director -
Mark Wegman,
Director -
Toby Wegman,
Director -
Sarah McCabe,
Stern Investor Relations -
Michael Sherman,
Independent Director -
Corey Fishman,
Independent Director -
Alex Monteith,
Senior Vice President and Chief Business Officer -
Patrick Hutchison,
Chief Financial Officer -
Joseph Truitt,
Chief Executive Officer, Director -
Jeffrey Kenneth Vogel,
-
Jyrki Mattila,
Director -
Thomas Wegman,
President -
Of Edwin H. Wegman Estate,
10% owner -
Patrick M Caldwell,
Principal Financial Officer -
Partners Lp Bio,
10% owner -
Albert Horcher,
-
Lawrence Dobroff,
CFO -
Max Link,
Director -
Henry Morgan,
Director -
George M Gould,
Director -
Matthew Geller,
Director -
Capital Management, Llc Kol...,
-
Capital Management, Llcra C...,
-
Capital Management, Llcaldr...,
-
Capital Management, Llc Kol...,
-
Capital Management, Llcra C...,
-
J Kevin Buchi,
Chief Executive Officer -
International Plc Endo,
10% owner